全文获取类型
收费全文 | 992篇 |
免费 | 54篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 17篇 |
妇产科学 | 15篇 |
基础医学 | 183篇 |
口腔科学 | 23篇 |
临床医学 | 110篇 |
内科学 | 181篇 |
皮肤病学 | 12篇 |
神经病学 | 91篇 |
特种医学 | 48篇 |
外国民族医学 | 1篇 |
外科学 | 149篇 |
综合类 | 15篇 |
预防医学 | 50篇 |
眼科学 | 28篇 |
药学 | 62篇 |
中国医学 | 11篇 |
肿瘤学 | 43篇 |
出版年
2024年 | 1篇 |
2023年 | 14篇 |
2022年 | 37篇 |
2021年 | 100篇 |
2020年 | 50篇 |
2019年 | 70篇 |
2018年 | 55篇 |
2017年 | 58篇 |
2016年 | 42篇 |
2015年 | 43篇 |
2014年 | 66篇 |
2013年 | 69篇 |
2012年 | 94篇 |
2011年 | 82篇 |
2010年 | 35篇 |
2009年 | 27篇 |
2008年 | 39篇 |
2007年 | 32篇 |
2006年 | 33篇 |
2005年 | 26篇 |
2004年 | 17篇 |
2003年 | 15篇 |
2002年 | 12篇 |
2001年 | 7篇 |
2000年 | 3篇 |
1999年 | 1篇 |
1998年 | 1篇 |
1996年 | 4篇 |
1995年 | 1篇 |
1994年 | 2篇 |
1992年 | 3篇 |
1991年 | 2篇 |
1989年 | 1篇 |
1987年 | 1篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1978年 | 1篇 |
1976年 | 1篇 |
1974年 | 1篇 |
排序方式: 共有1050条查询结果,搜索用时 31 毫秒
21.
Shirvani Hossein Rostamkhani Fatemeh Arabzadeh Ehsan Mohammadi Faezeh Mohammadi Fatemeh 《Sport Sciences for Health》2021,17(4):849-854
Sport Sciences for Health - The widespread prevalence and mortality of coronavirus diseases-2019 (COVID-19) lead many researchers to study the SARS-CoV-s2 infection to find a treatment for this... 相似文献
22.
23.
Xu Zheyu Anderson Kirstie N. Saffari Seyed Ehsan Lawson Rachael A. Chaudhuri K. Ray Brooks David Pavese Nicola 《Journal of neurology》2021,268(1):312-320
Journal of Neurology - Sleep disorders can occur in early Parkinson’s disease (PD). However, the relationship between different sleep disturbances and their longitudinal evolution has not... 相似文献
24.
Shirazi Mohsen Ahmad Akhoundi Mohammad Sadegh Javadi Ehsan Kamali Abbas Motahhari Pouria Rashidpour Mahsa Chiniforush Nasim 《Lasers in medical science》2015,30(2):713-718
Lasers in Medical Science - Low-level laser has been indicated to have the capability to facilitate the differentiation of the osteoclastic and osteoblastic cells which are responsible for the bone... 相似文献
25.
Ventricular Assist Devices and Increased Blood Product Utilization for Cardiac Transplantation 下载免费PDF全文
26.
Olle Muren Ehsan Akbarian Mats Salemyr Henrik Bodén Thomas Eisler André Stark Olof Sk?ldenberg 《Acta orthopaedica》2015,86(5):569-574
Background and purpose
We have previously shown that during the first 2 years after total hip arthroplasty (THA), periprosthetic bone resorption can be prevented by 6 months of risedronate therapy. This follow-up study investigated this effect at 4 years.Patients and methods
A single-center, double-blind, randomized placebo-controlled trial was carried out from 2006 to 2010 in 73 patients with osteoarthritis of the hip who were scheduled to undergo THA. The patients were randomly assigned to receive either 35 mg risedronate or placebo orally, once a week, for 6 months postoperatively. The primary outcome was the percentage change in bone mineral density (BMD) in Gruen zones 1 and 7 in the proximal part of the femur at follow-up. Secondary outcomes included migration of the femoral stem and clinical outcome scores.Results
61 of the 73 patients participated in this 4-year (3.9- to 4.1-year) follow-up study. BMD was similar in the risedronate group (n = 30) and the placebo group (n = 31). The mean difference was −1.8% in zone 1 and 0.5% in zone 7. Migration of the femoral stem, the clinical outcome, and the frequency of adverse events were similar in the 2 groups.Interpretation
Although risedronate prevents periprosthetic bone loss postoperatively, a decrease in periprosthetic BMD accelerates when therapy is discontinued, and no effect is seen at 4 years. We do not recommend the use of risedronate following THA for osteoarthritis of the hip.Adaptive bone remodeling around the femoral stem following total hip arthroplasty (THA) results in regional loss of bone mass, especially in proximal parts of the femur—most of which takes place within the first postoperative year (Bodén et al. 2006, Sköldenberg et al. 2006). Periprosthetic bone loss may predispose to periprosthetic fracture, aseptic loosening, and difficulties at revision surgery (Lindahl 2007, Streit et al. 2011, Sköldenberg et al. 2014).The bisphosphonate (BP) risedronate has been used successfully to prevent osteoporotic fractures, mainly in the hip and vertebrae, by inhibiting osteoclast activity (McClung et al. 2001). In recent years, the possible use of BPs to prevent or ameliorate periprosthetic adaptive bone resorption, osteolysis, and implant migration has been investigated thoroughly in animal models and humans. The short-term results of several studies showing the effects of postoperative BP treatment in reducing periprosthetic bone loss up to a year after the arthroplasty have already been published (Venesmaa et al. 2001, Wilkinson et al. 2001, Hennigs et al. 2002, Wilkinson et al. 2005, Arabmotlagh et al. 2006).We have previously found that risedronate given once a week for 6 months after THA reduces periprosthetic bone resorption around an uncemented femoral stem in the first and second postoperative year (Sköldenberg et al. 2011). We now report the 4-year outcome in the same cohort. 相似文献27.
28.
Ehsan Valavi Ali Ahmadzadeh Parisa Amoori Aidin Daneshgar 《Indian journal of pediatrics》2014,81(7):665-669
Objective
To estimate the frequency of acquired ADAMTS13 deficiency in severe cases of Hemiscorpius lepturus stung patients and the frequency of acute kidney injury (AKI) in these patients.Methods
Sixty scorpion stung children who were referred with severe hemolysis and hemoglobinuria were studied. None of them had received blood products and no one had a past medical history of renal failure.Results
Plasma levels of ADAMTS13 and ADAMTS13 antibody (IgG) were measured using ELISA. ADAMTS13 was decreased in 91.7 % of patients and the anti-ADAMTS13 antibody (Ab) was increased in 98.3 %. ADAMTS13 decreased in all of the patients with acute kidney injury and none of those with normal levels of ADAMTS13 developed renal failure; all patients with AKI had also increased levels of ADAMTS13Ab. Acute kidney injury was found in 23.3 % and had significant association with severe anemia, thrombocytopenia, pyuria, hematuria and considerable proteinuria (p?<?0.001). Disseminated intravascular coagulation (DIC) and Hemolytic uremic syndrome (HUS) developed in 6.7 % and 10 % respectively.Conclusions
The index findings demonstrate that Hemiscorpius lepturus sting is usually associated with ADAMTS13 deficiency, and increased ADAMTS13 autoantibody. These combined mechanisms may contribute to scorpion sting-induced coagulopathies and may predispose patients to develop DIC and HUS. 相似文献29.
There are no standardized management algorithms for neonates with Pierre Robin sequence. Currently available literature is variable in terms of outcomes assessed across studies. In this paper, we have aimed to summarize the currently available literature on longitudinal sleep and respiratory outcomes in Pierre Robin sequence neonates with a focus on identifying gaps in literature and areas for future research development.
相似文献30.
Hassan Ashktorab Omid Entezari Mehdi Nouraie Ehsan Dowlati Wayne Frederick Alfreda Woods Edward Lee Hassan Brim Duane T. Smoot Firoozeh Ghadyari Farin Kamangar Hadie Razjouyan 《Digestive diseases and sciences》2012,57(11):2924-2928